| Snowflake Score | |
|---|---|
| Valuation | 0/6 |
| Future Growth | 6/6 |
| Past Performance | 2/6 |
| Financial Health | 5/6 |
| Dividends | 1/6 |
Rewards
Risk Analysis
No risks detected for 603392 from our risk checks.
Beijing Wantai Biological Pharmacy Enterprise Co., Ltd. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | CN¥64.64 |
| 52 Week High | CN¥88.00 |
| 52 Week Low | CN¥40.14 |
| Beta | 2.32 |
| 1 Month Change | -9.46% |
| 3 Month Change | 7.06% |
| 1 Year Change | -14.30% |
| 3 Year Change | -39.97% |
| 5 Year Change | n/a |
| Change since IPO | 1,357.99% |
Recent News & Updates
Some Investors May Be Willing To Look Past Beijing Wantai Biological Pharmacy Enterprise's (SHSE:603392) Soft Earnings
Apr 04
Things Look Grim For Beijing Wantai Biological Pharmacy Enterprise Co., Ltd. (SHSE:603392) After Today's Downgrade
Apr 02Recent updates
Some Investors May Be Willing To Look Past Beijing Wantai Biological Pharmacy Enterprise's (SHSE:603392) Soft Earnings
Apr 04Things Look Grim For Beijing Wantai Biological Pharmacy Enterprise Co., Ltd. (SHSE:603392) After Today's Downgrade
Apr 02Earnings Tell The Story For Beijing Wantai Biological Pharmacy Enterprise Co., Ltd. (SHSE:603392) As Its Stock Soars 27%
Feb 28Shareholder Returns
| 603392 | CN Biotechs | CN Market | |
|---|---|---|---|
| 7D | -7.9% | 0.3% | 1.6% |
| 1Y | -14.3% | -24.2% | -15.1% |
Price Volatility
| 603392 volatility | |
|---|---|
| 603392 Average Weekly Movement | 9.6% |
| Biotechs Industry Average Movement | 7.9% |
| Market Average Movement | 8.8% |
| 10% most volatile stocks in CN Market | 12.6% |
| 10% least volatile stocks in CN Market | 5.3% |
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1991 | 3,843 | Zixin Qiu | www.ystwt.com |
Beijing Wantai Biological Pharmacy Enterprise Co., Ltd. researches, develops, produces, distributes, and sells infectious disease diagnostic reagents and vaccines in China and internationally. The company provides COVID 19, HIV and HTLV, Hepatitis, EV-71, and Tuberculosis diagnostics test kits; Hepatitis C and Syphilis detection reagents; automated immunoassays; ELISA kits and rapid tests for infectious disease diagnostics; chemiluminescence and clinical chemistry reagents; immunodiagnostic reagents; and Hepatitis E and human papillomavirus vaccines.
Beijing Wantai Biological Pharmacy Enterprise Co., Ltd. Fundamentals Summary
| 603392 fundamental statistics | |
|---|---|
| Market cap | CN¥83.75b |
| Earnings (TTM) | CN¥1.25b |
| Revenue (TTM) | CN¥5.51b |
65.7x
P/E Ratio14.9x
P/S RatioIs 603392 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 603392 income statement (TTM) | |
|---|---|
| Revenue | CN¥5.51b |
| Cost of Revenue | CN¥1.00b |
| Gross Profit | CN¥4.51b |
| Other Expenses | CN¥3.26b |
| Earnings | CN¥1.25b |
Last Reported Earnings
Dec 31, 2023
Next Earnings Date
Apr 26, 2024
| Earnings per share (EPS) | 0.98 |
| Gross Margin | 81.81% |
| Net Profit Margin | 22.64% |
| Debt/Equity Ratio | 2.2% |
How did 603392 perform over the long term?
See historical performance and comparison